DANIELLE SHATTUCK: Open Payments
NPI 1407534985 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,320 in 72 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $902 · 2025 $2,320
Food & beverage: $2,320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $503 |
| Janssen Biotech, Inc. | 11 | $354 |
| Regeneron Healthcare Solutions, Inc. | 8 | $291 |
| Incyte Corporation | 10 | $280 |
| Arcutis Biotherapeutics, Inc. | 3 | $264 |
| Amgen Inc. | 1 | $125 |
| PFIZER INC. | 6 | $122 |
| GENZYME CORPORATION | 3 | $95 |
| LEO Pharma Inc. | 3 | $68 |
| Galderma Laboratories, L.P. | 3 | $59 |
Products named: TREMFYA, DUPIXENT, OPZELURA, Zoryve, SKYRIZI, OTEZLA, CIBINQO, RINVOQ.
Industry payments across NY — which companies pay providers there.
